In the day August 29, 2025, it happened Cura Talks Gramado whose central theme was Integrative Care for Breast Cancer, carried out at Lupicinio Rodrigues Theater — Wish Serrano Resort, in Gramdo/RS. With an audience of 177 enrolled, 41% of whom were multidisciplinary and 24% comprised of patients, the meeting brought together specialists from different areas of health to discuss everything from prevention and early diagnosis to treatment and post-treatment challenges, with special attention to the reality of young women with breast cancer.

‍

Debate highlights

The opening was conducted by Luciana Pereira, Project Coordinator of the Cura Project Institute, who moderated the module on breast cancer subtypes and their impact on treatment, with the participation of the oncologist Dr. Gustavo Werutsky And lectures from Dr. Max Mano, who explained the role of molecular profiling in therapeutic personalization, and of Dr. Heloisa Resende, which addressed strategies to reduce the time between diagnosis and treatment initiation. Already the Dr. Patrícia Prolla highlighted the importance of genetic tests for selected patients, an increasingly relevant topic in clinical practice.

In the second module, experts discussed the increase in incidence of breast cancer in young women. A Dr. Angélica Nogueira provided data on the systemic approach in these cases, while Dr. Mónica Rodríguez presented the advances of oncoplastic surgery. The debate was moderated by Fernanda Schwyter and also included contributions from Dr. Sergio Azevedo And from Dr. Heloisa Resende, reinforcing the importance of an integral and multidisciplinary perspective.

In the afternoon, the focus was on multidisciplinary approach, moderated by the nurse Ariane Pereira Osório. Highlights included the nutritionist's lecture Dr. Fernanda Bortolon, who emphasized the importance of adequate nutrition to adhere to treatment and combat fake news; from the dentist Dr. Bianca Abreu de Azevedo, who recalled the need for oncological dentistry before and during therapy; of the physiotherapist Alessandra Tessaro, who spoke about functional rehabilitation after breast surgery; and about the oncologist Dr. Jesse Lopes, who addressed the benefits of exercise during treatment. The pharmacist Virginia Webber presented cases of patients in clinical research, highlighting how these studies increase survival and quality of life. The oncologist also participated Dr. Tomas Reinert, who spoke about the work of the Brazilian Breast Cancer Studies Group of which he is director. In addition to Dr. Roberto J. Arai who is Chief Operating Officer of the Cura Project Institute, responsible for operational management focusing on innovation, clinical research and social impact.

Another highlight was the panel with the Dr. Laura Testa, Dr. Maira Caleffi and Alexandre Bem, Moderated by the Cura Counselor, Catia Duarte, who reflected on public policies and the challenges of accessing innovative treatments in Brazil, with the theme of PCDT for Breast Cancer.

The closing brought about a welcoming debate about life after treatment, moderated by Fernanda Schwyter, with the oncologist Dr. Luciana Landeiro, who presented guidelines for post-treatment follow-up, Dr. Aline Coelho Gonçalves, who shared the most recent studies of ASCO 2025 about patients' quality of life and well-being and the oncologist Dr. Alessandra Morelle. The discussion was widely attended by the public, especially around the topic of sexual health and loss of libido after treatment.

‍

A meeting of integration and impact

O Cura Talks Gramado emphasized the importance of integrated care and the role played by patients in the construction of their treatment journeys. O Dr. Carlos Barrios, at the closing, emphasized the commitment to maintain the support of the Gramado Breast Cancer Congress for the Cure Project, strengthening research and innovation in oncology.

The event was supported by institutional support from Femama, Camaleão Institute, Awa'Pé Dragon Boat Team, GBECAM and LACOG, in addition to Support from the Gramado Breast Cancer Congress. The master sponsorship was from Roche, with the support of Daiichi Sankyo And from Gilead, institutions that reinforce their commitment to the science and advancement of oncology in Brazil.

The full recording will be available on the digital platforms of Cura Project Institute, expanding the access of professionals, patients, and researchers to the discussions that marked this edition.

Follow the Cura Project Institute on social media: @projetocura
Until the next edition of Cura Talks!